{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:36:41Z","timestamp":1774492601760,"version":"3.50.1"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.2169\/internalmedicine.4224-24","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T22:11:41Z","timestamp":1731017501000},"page":"201-207","source":"Crossref","is-referenced-by-count":3,"title":["Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination"],"prefix":"10.2169","volume":"64","author":[{"given":"Akira","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuma","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Yasutomi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh Shunsuke","family":"Colvin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenao","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Wato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kagawa Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Murakami Y, Shinohara M, Oka Y, et al. Myocarditis following a COVID-19 messenger RNA vaccination: a Japanese case series. Intern Med 61: 501-505, 2022.","DOI":"10.2169\/internalmedicine.8731-21"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alqatari S, Ismail M, Hasan M, et al. Emergence of post COVID-19 vaccine autoimmune diseases: a single center study. Infect Drug Resist 16: 1263-1278, 2023.","DOI":"10.2147\/IDR.S394602"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hasegawa N, Matsuoka R, Ishikawa N, et al. Autoimmune hepatitis with history of HCV treatment triggered by COVID-19 vaccination: case report and literature review. Clin J Gastroenterol 15: 791-795, 2022.","DOI":"10.1007\/s12328-022-01654-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ueno M, Takabatake H, Itakura J, et al. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review. Clin J Gastroenterol 16: 554-558, 2023.","DOI":"10.1007\/s12328-023-01794-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, K\u00fcmpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 269: 55-58, 2022.","DOI":"10.1007\/s00415-021-10648-w"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garrido I, Lopes S, Sim\u00f5es MS, et al. Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence. J Autoimmun 125: 102741, 2021.","DOI":"10.1016\/j.jaut.2021.102741"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR. The emergence of new-onset SLE following SARS-CoV-2 vaccination. QJM 114: 739-740, 2021.","DOI":"10.1093\/qjmed\/hcab229"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. M\u00f6nkem\u00fcller K, Abdullayeva E, Manovski K, Cacho-D\u00edaz M. Ischemic colitis after COVID-19 mRNA vaccine. Endoscopy 54: E765-E766, 2022.","DOI":"10.1055\/a-1816-7631"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chey SW, Westerhoff M, Chey WD. Transient lymphocytic colitis after SARS-CoV2 mRNA vaccine. Am J Gastroenterol 117: 685-687, 2022.","DOI":"10.14309\/ajg.0000000000001673"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Doman T, Saito H, Tanaka Y, et al. Colitis with hypereosinophilia following the second dose of the BNT162b2 mRNA COVID-19 vaccine: a case report with a literature review. Intern Med 62: 865-869, 2023.","DOI":"10.2169\/internalmedicine.0518-22"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kuo HL, Lin TY, Leong PY. Case report of new-onset ulcerative colitis after MVC-COVI1901 vaccine injection for SARS-CoV-2. Int J Rheum Dis 26: 1594-1598, 2023.","DOI":"10.1111\/1756-185X.14637"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ak \u00c7, Sayar S, Adal\u0131 G, \u00d6zdil K. Acute severe ulcerative colitis after mRNA coronavirus disease 2019 vaccination: can mRNA vaccines unmask inflammatory bowel diseases? ACG Case Rep J 9: e00806, 2022.","DOI":"10.14309\/crj.0000000000000806"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shimodaira Y, Watanabe K, Takahashi S, Koizumi S, Iijima K. Inflammatory bowel disease triggered by BNT162b2 mRNA vaccination for SARS-CoV-2. Inflamm Bowel Dis 28: e75, 2022.","DOI":"10.1093\/ibd\/izab297"},{"key":"14","unstructured":"14. Takahashi Y, Shimodaira Y, Yoshida T, et al. A case of severe inflammatory bowel disease triggered by vaccination with SARS-CoV-2 mRNA. Nihon Shokakibyo Gakkai Zasshi (J Jpn Soc Gastroenterol) 120: 325-329, 2023."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Taida T, Kato J, Ishikawa K, et al. Severe ulcerative colitis induced by COVID-19 vaccination. Clin J Gastroenterol 17: 447-450, 2024.","DOI":"10.1007\/s12328-024-01926-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 6: 104, 2021.","DOI":"10.1038\/s41541-021-00369-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Trougakos IP, Terpos E, Alexopoulos H, et al. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med 28: 542-554, 2022.","DOI":"10.1016\/j.molmed.2022.04.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271-280, 12020.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450-454, 2003.","DOI":"10.1038\/nature02145"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158: 1831-1833.e3, 2020.","DOI":"10.1053\/j.gastro.2020.02.055"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 13: 120, 2020.","DOI":"10.1186\/s13045-020-00954-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bekal S, Husari G, Okura M, Huang CA, Bukari MS. Thrombosis development after mRNA COVID-19 vaccine administration: a case series. Cureus 15: e41371, 2023.","DOI":"10.7759\/cureus.41371"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med 16: 803-804, 2021.","DOI":"10.1007\/s11739-021-02685-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sun MY, Maykel JA. Ischemic colitis. Clin Colon Rectal Surg 20: 5-12, 2007.","DOI":"10.1055\/s-2007-970194"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Vadal\u00e0 M, Poddighe D, Laurino C, Palmieri B. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? EPMA J 8: 295-311, 2017.","DOI":"10.1007\/s13167-017-0101-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Trier NH, Houen G. Antibody cross-reactivity in auto-immune diseases. Int J Mol Sci 24: 13609, 2023.","DOI":"10.3390\/ijms241713609"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in auto immune diseases. Clin Immunol 217: 108480, 2020.","DOI":"10.1016\/j.clim.2020.108480"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Iijima S, Enami C, Sato M, Tsunoda T, Otoyama K. Neutrophilic dermatosis with necrobiotic changes as an unusual manifestation after the first shot of a COVID-19 mRNA vaccine together with a high fever and liver injury. J Cutan Immunol Allergy 6: 49-54, 2022.","DOI":"10.1002\/cia2.12279"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tan EM. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity. Pediatr Infect Dis J 7 (5 Suppl): S3-S9, 1988.","DOI":"10.1097\/00006454-198805001-00002"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_4224-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T03:30:32Z","timestamp":1737171032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_4224-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4224-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"4224-24"}}